Cargando…

Sam68 is a novel marker for aggressive neuroblastoma [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140227/ http://dx.doi.org/10.2147/OTT.S58769

Ejemplares similares

Sam68 is a novel marker for aggressive neuroblastoma
por: Zhao, Xiaohong, et al.
Publicado: (2013)

Sam68 is absolutely required for Rev function and HIV-1 production
por: Modem, Suhasini, et al.
Publicado: (2005)

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum]
Publicado: (2021)

Corrigendum to “Design of CGMP Production of (18)F- and (68)Ga-Radiopharmaceuticals”
por: Chi, Yen-Ting, et al.
Publicado: (2016)

Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ [EBioMedicine 49 (2019) 82–95]
por: Vega, Francisco M., et al.
Publicado: (2020)

Corrigendum to: Development and Characterization of Novel Polymorphic Microsatellite Markers for Tapinoma indicum (Hymenoptera: Formicidae)
por: Lim, Li Yang, et al.
Publicado: (2021)

Corrigendum to “asynchrony of senescence among phenotypic traits in a wild mammal population” [Exp. Gerontol. 71 (2015) 56–68]
por: Hayward, Adam D., et al.
Publicado: (2017)

Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status [Corrigendum]
Publicado: (2019)

Corrigendum to “ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension”
por: Waligóra, Marcin, et al.
Publicado: (2018)

ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]
Publicado: (2022)

Comprehensive Mechanism, Novel Markers and Multidisciplinary Treatment of Severe Acute Pancreatitis-Associated Cardiac Injury – A Narrative Review [Corrigendum]
Publicado: (2021)

Corrigendum: Bone Metabolic Markers in Patients with Obstructive Sleep Apnea Syndrome
Publicado: (2018)

Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease [Corrigendum]
Publicado: (2022)

Corrigendum to “Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia”
por: Vaseghi, Golnaz, et al.
Publicado: (2023)

Corrigendum: Analysis of platelet parameters and activation markers in hematologic metastases of lung cancer
Publicado: (2019)

The novel anti-neuroblastoma agent PF403, inhibits proliferation and invasion in vitro and in brain xenografts
por: Li, Chao, et al.
Publicado: (2022)

Corrigendum: Expression of the spinal 5-HT7 receptor and p-ERK pathway in the carrageenan inflammatory pain of rats (Korean J Anesthesiol 2015 April 68(2): 170-174)
por: Cho, Soo Young, et al.
Publicado: (2015)

The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia [Corrigendum]
Publicado: (2016)

Corrigendum to “Single Bout Exercise in Children with Juvenile Idiopathic Arthritis: Impact on Inflammatory Markers”
por: Rochette, Emmanuelle, et al.
Publicado: (2018)

Corrigendum to “PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer”
por: Li, Guang, et al.
Publicado: (2021)

Corrigendum: A histamine-gated channel is an efficient negative selection marker for C. elegans transgenesis
Publicado: (2021)

Corrigendum to “Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma”
por: Fatima, Naz, et al.
Publicado: (2017)

Corrigendum to “Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms” [Mol. Cell. Endocrinol. 440 15 January 2017 57–68]
por: Chen, S.C., et al.
Publicado: (2017)

ITSN1 regulates SAM68 solubility through SH3 domain interactions with SAM68 proline-rich motifs
por: Pankivskyi, S., et al.
Publicado: (2020)

Corrigendum to “miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus”
por: Zhou, Shaolan, et al.
Publicado: (2021)

Corrigendum to “Release of Danger Signals during Ischemic Storage of the Liver: A Potential Marker of Organ Damage?”
por: Liu, Anding, et al.
Publicado: (2022)

Vitamin D supplementation and immune-related markers: An update from nutrigenetic and nutrigenomic studies – CORRIGENDUM
por: Antony Dhanapal, Anto Cordelia Tanislaus, et al.
Publicado: (2023)

Corrigendum to “A Novel Curcumin-Galactomannoside Complex Delivery System Improves Hepatic Function Markers in Chronic Alcoholics: A Double-Blinded, randomized, Placebo-Controlled Study”
por: Krishnareddy, Naveen T., et al.
Publicado: (2019)

CORRIGENDUM FOR “A Novel TBX1 Variant Causing Hypoparathyroidism and Deafness”
Publicado: (2020)

Corrigendum to “How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Déu in Barcelona, Spain”: [ESMO Open, 7 (2022) 100462]
por: Castañeda, A., et al.
Publicado: (2022)

Corrigendum to “Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung”
por: Losmanová, Tereza, et al.
Publicado: (2021)

Corrigendum: IRB Approval Number Correction. Cardiac Dysfunction in Association with Increased Inflammatory Markers in Primary Aldosteronism
por: Lim, Jung Soo, et al.
Publicado: (2020)

Neuroblastoma in monozygotic twins – a case of probable twin to twin metastasis
por: Anderson, J, et al.
Publicado: (2002)

Corrigendum
Publicado: (2014)

Corrigendum
Publicado: (2014)

Corrigendum
Publicado: (2014)

Corrigendum
Publicado: (2014)

Corrigendum
Publicado: (2014)

Corrigendum
Publicado: (2014)

Corrigendum
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_as980dephtbb05n5jfpiq3usbi